Gilead Sciences (NASDAQ:GILD) CFO Robin L. Washington sold 33,556 shares of the stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $95.56, for a total transaction of $3,206,611.36. Following the completion of the sale, the chief financial officer now directly owns 49,832 shares of the company’s stock, valued at approximately $4,761,946. The sale was disclosed in a filing with the … Continue reading Stocks to Watch : Gilead Sciences Inc. (NASDAQ:GILD), Sprint (NYSE:S), DWSN, Prana Biotechnology Limited (NASDAQ:PRAN), Lime Energy (NASDAQ:LIME)